Bhagiradha Chemicals & Industries Limited reported a significant improvement in profitability for the quarter ended June 30, 2026, with standalone net profit rising 29% quarter-on-quarter and surging 29% year-on-year. The Hyderabad-based specialty chemicals manufacturer posted a consolidated net profit of ₹1,332.92 crore, compared to ₹397.91 crore in Q1FY25, marking a substantial turnaround in earnings performance.

The company’s Board of Directors, chaired by Managing Director S. Chandra Sekhar, approved the unaudited financial results on August 03, 2026, pursuant to Regulation 30 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were reviewed by the Audit Committee and subjected to a limited review by the statutory auditors. The newspaper advertisement was published on August 04, 2026, in Financial Express and Mana Telangana.

Financial Performance Highlights

Revenue from operations grew robustly, reflecting strong demand in the chemical sector. Standalone revenue increased 38% year-on-year to ₹17,575.67 crore, while consolidated revenue rose 60% to ₹19,880.13 crore. This top-line growth was accompanied by improved operational efficiency, leading to higher margins.

What the Numbers Show

The divergence between standalone and consolidated performance highlights the impact of subsidiaries on overall group profitability. While standalone PAT grew steadily, consolidated PAT saw a more dramatic increase, suggesting that associated companies or subsidiaries contributed disproportionately to the bottom line in Q1FY26. The equity share capital remained unchanged at ₹1,296.69 crore, indicating no new equity dilution during the period. Other equity reserves stood at ₹71,059.06 crore for standalone and ₹68,535.00 crore for consolidated operations as per the previous year’s audited balance sheet.

Bhagiradha Chemicals & Industries reported a robust start to FY27, with standalone net profit rising 29% year-on-year to ₹106.8 million for the quarter ended June 30, 2026. The Hyderabad-based agrochemical manufacturer saw revenue from operations surge to ₹173.7 million, up from ₹123.8 million in the corresponding period of the previous year. This growth underscores sustained demand in its primary crop protection segment, while improved operational efficiency contributed to margin expansion.

The Board of Directors, at a meeting held on August 3, 2026, approved the unaudited standalone and consolidated financial results. The results were reviewed by the Audit Committee and subjected to a limited review by the statutory auditors, R. Kankaria & Uttam Singhi Chartered Accountants, who issued an unmodified opinion. The financial statements were prepared in accordance with Indian Accounting Standards (Ind-AS) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Standalone Financial Performance

Standalone revenue from operations increased significantly to ₹173.7 million (₹17,367.32 lakh) from ₹123.8 million (₹12,377.78 lakh) in Q1FY26. Total income, including other income of ₹2.1 million, stood at ₹175.8 million. Despite higher costs of materials consumed at ₹122.2 million compared to ₹73.7 million year-ago, the company managed to expand its profit before tax to ₹143.4 million from ₹72.1 million.

The net profit for the quarter was ₹106.8 million, a notable improvement over the ₹82.9 million reported in Q1FY26. Basic earnings per share (annualised) rose to ₹0.82 from ₹0.64. The tax expense for the quarter was ₹36.6 million, comprising current tax of ₹33.3 million and deferred tax charges.

Consolidated Results and Segment Focus

On a consolidated basis, which includes wholly-owned subsidiary Bheema Fine Chemicals Private Limited, the group reported net profit of ₹133.3 million, up sharply from ₹39.8 million in Q1FY26. Consolidated revenue from operations reached ₹195.0 million, compared to ₹123.8 million in the prior year period. The significant jump in consolidated profit reflects synergies and scale benefits within the group structure.

The company operates in a single reportable segment: Crop Protection Chemicals, as per Ind-AS 108. Executive Director & CEO A. Arvind Kumar highlighted the strong performance in the segment, attributing the growth to effective cost management and favorable market conditions for crop protection chemicals. The statutory auditors confirmed that the figures for the three months ended March 31, 2026, are balancing figures between audited full-year figures and published year-to-date figures up to Q3FY26.

What the Numbers Show

The nearly doubling of profit before tax alongside a 40% revenue increase suggests substantial operating leverage. While material costs rose proportionately with sales, other expenses remained relatively stable, allowing margins to expand. The divergence between standalone and consolidated profit growth indicates that the subsidiary, Bheema Fine Chemicals, contributed disproportionately to the bottom-line improvement, likely due to lower overhead absorption or specific project completions within the subsidiary during the quarter.